Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA (2022) The global burden of cardiovascular diseases and risk: a compass for future health. J Am Coll Cardiol 80(25):2361–2371. https://doi.org/10.1016/j.jacc.2022.11.005

Article  PubMed  Google Scholar 

Leitner DR, Frühbeck G, Yumuk V, Schindler K, Micic D, Woodward E, Toplak H (2017) Obesity and type 2 diabetes: two diseases with a need for combined treatment strategies - EASO can lead the way. Obes Facts 10(5):483–492. https://doi.org/10.1159/000480525

Article  PubMed  PubMed Central  Google Scholar 

Grams J, Garvey WT (2015) Weight loss and the prevention and treatment of type 2 diabetes using lifestyle therapy, pharmacotherapy, and bariatric surgery: mechanisms of action. Curr Obes Rep 4(2):287–302. https://doi.org/10.1007/s13679-015-0155-x

Article  CAS  PubMed  Google Scholar 

TM Powell-Wiley P Poirier LE Burke JP Després P Gordon-Larsen CJ Lavie SA Lear CE Ndumele IJ Neeland P Sanders MP St-Onge American Heart Association Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Epidemiology and Prevention; and Stroke Council Obesity and Cardiovascular Disease (2021) A scientific statement from the American heart association. Circulation 143(21):e984–e1010. https://doi.org/10.1161/CIR.0000000000000973

Article  Google Scholar 

Ward ZJ, Bleich SN, Cradock AL, Barrett JL, Giles CM, Flax C, Long MW, Gortmaker SL (2019) Projected U.S. state-level prevalence of adult obesity and severe obesity. N Engl J Med 381(25):2440–2450. https://doi.org/10.1056/NEJMsa1909301

Article  PubMed  Google Scholar 

Solomon SD, Vaduganathan M, Claggett BL, de Boer RA, DeMets D, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez F, Shah SJ, Belohlavek J, Chiang CE, Willem Borleffs CJ, Comin-Colet J, Dobreanu D, Drozdz J, Fang JC, Alcocer Gamba MA, Al Habeeb W, Han Y, Cabrera Honorio JW, Janssens SP, Katova T, Kitakaze M, Merkely B, O’Meara E, Kerr Saraiva JF, Tereschenko SN, Thierer J, Vardeny O, Verma S, Vinh PN, Wilderäng U, Zaozerska N, Lindholm D, Petersson M, McMurray JJV (2022) Baseline characteristics of patients with HF with mildly reduced and preserved ejection fraction: deliver trial. JACC Heart Fail 10(3):184–197. https://doi.org/10.1016/j.jchf.2021.11.006

Article  PubMed  Google Scholar 

Lavie CJ, Pandey A, Lau DH, Alpert MA, Sanders P (2017) Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis: effects of weight loss and exercise. J Am Coll Cardiol 70(16):2022–2035. https://doi.org/10.1016/j.jacc.2017.09.002

Article  PubMed  Google Scholar 

Di Lorenzo N, Antoniou SA, Batterham RL, Busetto L, Godoroja D, Iossa A, Carrano FM, Agresta F, Alarçon I, Azran C, Bouvy N, Balaguè Ponz C, Buza M, Copaescu C, De Luca M, Dicker D, Di Vincenzo A, Felsenreich DM, Francis NK, Fried M, Gonzalo Prats B, Goitein D, Halford JCG, Herlesova J, Kalogridaki M, Ket H, Morales-Conde S, Piatto G, Prager G, Pruijssers S, Pucci A, Rayman S, Romano E, Sanchez-Cordero S, Vilallonga R, Silecchia G (2020) Clinical practice guidelines of the European association for endoscopic surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC. EASO and ESPCOP Surg Endosc 34(6):2332–2358. https://doi.org/10.1007/s00464-020-07555-y

Article  PubMed  Google Scholar 

Jordan J, Birkenfeld AL (2016) Cardiometabolic crosstalk in obesity-associated arterial hypertension. Rev Endocr Metab Disord 17(1):19–28. https://doi.org/10.1007/s11154-016-9348-1

Article  CAS  PubMed  Google Scholar 

Alpert MA, Omran J, Bostick BP (2016) Effects of obesity on cardiovascular hemodynamics, cardiac morphology, and ventricular function. Curr Obes Rep 5(4):424–434. https://doi.org/10.1007/s13679-016-0235-6

Article  PubMed  Google Scholar 

Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR, Sowers JR (2021) Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism 119:154766. https://doi.org/10.1016/j.metabol.2021.154766

Article  CAS  PubMed  Google Scholar 

Paavonsalo S, Hariharan S, Lackman MH, Karaman S (2020) Capillary rarefaction in obesity and metabolic diseases-organ-specificity and possible mechanisms. Cells 9(12):2683

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tona F, Serra R, Di Ascenzo L, Osto E, Scarda A, Fabris R, Montisci R, Famoso G, Tellatin S, Foletto M, Giovagnoni A, Iliceto S, Vettor R (2014) Systemic inflammation is related to coronary microvascular dysfunction in obese patients without obstructive coronary disease. Nutr Metab Cardiovasc Dis 24(4):447–453. https://doi.org/10.1016/j.numecd.2013.09.021

Article  CAS  PubMed  Google Scholar 

VillarrealCalderon JR, CuellarTamez R, Castillo EC, LunaCeron E, GarcíaRivas G, ElizondoMontemayor L (2021) Metabolic shift precedes the resolution of inflammation in a cohort of patients undergoing bariatric and metabolic surgery. Sci Rep. https://doi.org/10.1038/s41598-021-91393-y

Article  PubMed  PubMed Central  Google Scholar 

Riemekasten G, Philippe A, Näther M, Slowinski T, Müller DN, Heidecke H, Matucci-Cerinic M, Czirják L, Lukitsch I, Becker M, Kill A, van Laar JM, Catar R, Luft FC, Burmester GR, Hegner B, Dragun D (2011) Involvement of functional autoantibodies against vascular receptors in systemic sclerosis. Ann Rheum Dis 70(3):530–536. https://doi.org/10.1136/ard.2010.135772

Article  CAS  PubMed  Google Scholar 

Zhang X, Mirocha J, Aintablian T, Dimbil S, Moriguchi J, Arabia F, Kobashigawa JA, Reinsmoen N (2018) Revealing a new mode of sensitization induced by mechanical circulatory support devices: impact of anti-AT1 R antibodies. Clin Transpl. https://doi.org/10.1111/ctr.13178

Article  Google Scholar 

Buttrup Larsen S, Wallukat G, Schimke I, Sandager A, Tvilum Christensen T, Uldbjerg N, Tørring N (2018) Functional autoantibodies against endothelin-1 receptor type A and angiotensin II receptor type 1 in patients with preeclampsia. Pregn Hypertens 14:189–194. https://doi.org/10.1016/j.preghy.2018.10.002

Article  Google Scholar 

Tona F, Vadori M, Civieri G, Masiero G, Iop L, Antonelli G, Perazzolo Marra M, Bianco F, Cecere A, Lorenzoni G, Naumova N, Bernava G, Basso D, Plebani M, Cozzi E, Iliceto S (2023) Association of autoantibodies targeting endothelin type-A receptors with no-reflow in ST-elevation myocardial infarction. Atherosclerosis 378:117179. https://doi.org/10.1016/j.atherosclerosis.2023.06.970

Article  CAS  PubMed  Google Scholar 

Li Y, Tian J, Ma XR, Li RT, Zhang SL, Wang PL, Yin XC, Bian JW, Lei JH, Liu HR (2017) Increase in G protein-coupled receptor autoantibodies with decline of cardiac function in hypercholesterolemic rats. Eur Rev Med Pharmacol Sci 21(5):1065–1073

CAS  PubMed  Google Scholar 

Zhao L, Xu C, Xu J (2014) Autoantibodies against β1 receptor and AT1 receptor in type 2 diabetes patients with left ventricular dilatation. Cardiology 129(3):191–196. https://doi.org/10.1159/000365782

Article  CAS  PubMed  Google Scholar 

ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Seley JJ, Stanton RC, Gabbay RA, On behalf of the American diabetes association (2020) Classification and diagnosis of diabetes: standards of care in diabetes-2023. Diabetes Care. https://doi.org/10.2337/dc23-S002

Article  Google Scholar 

Cooke JP (2020) Endotheliopathy of Obesity. Circulation 142(4):380–383

Article  PubMed  PubMed Central  Google Scholar 

Virdis A (2016) Endothelial dysfunction in obesity: role of inflammation. High Blood Press Cardiovasc Prev 23(2):83–85. https://doi.org/10.1007/s40292-016-0133-8

Article  CAS  PubMed  Google Scholar 

Gregor MF, Hotamisligil GS (2011) Inflammatory mechanisms in obesity. Annu Rev Immunol 29:415–445. https://doi.org/10.1146/annurev-immunol-031210-101322

Article  CAS  PubMed  Google Scholar 

Li W, Li Z, Chen Y, Li S, Lv Y, Zhou W, Liao M, Zhu F, Zhou Z, Cheng X, Zeng Q, Liao Y, Wei Y (2014) Autoantibodies targeting AT1 receptor from patients with acute coronary syndrome upregulate proinflammatory cytokines expression in endothelial cells involving NF-κB pathway. J Immunol Res 2014:342693. https://doi.org/10.1155/2014/342693

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hiemann NE, Meyer R, Wellnhofer E, Schoenemann C, Heidecke H, Lachmann N, Hetzer R, Dragun D (2012) Non-HLA antibodies targeting vascular receptors enhance alloimmune response and microvasculopathy after heart transplantation. Transplantation 94(9):919–924. https://doi.org/10.1097/TP.0b013e3182692ad2

Article  CAS  PubMed  Google Scholar 

Dragun D, Müller DN, Bräsen JH, Fritsche L, Nieminen-Kelhä M, Dechend R, Kintscher U, Rudolph B, Hoebeke J, Eckert D, Mazak I, Plehm R, Schönemann C, Unger T, Budde K, Neumayer HH, Luft FC, Wallukat G (2005) Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 352(6):558–569. https://doi.org/10.1056/NEJMoa035717

Article  CAS  PubMed